Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
JAGX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
JAGX
Jaguar Health, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
JAGX
Jaguar Health, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
JAGX: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
JAGX, solid
LLY, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only JAGX
3
—
Venture Life
unlisted
supplier
—
Knight Therapeutics
unlisted
customer
—
Quadri Pharmaceuticals Store
unlisted
customer
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›
JAGX
Jaguar Health, Inc.
Change
0.39
▼
−3.29%
Mkt cap
$140,268
Revenue
$1M
Q2 FY26
Revenue
$12M
FY25
LLY
ELI Lilly & Co
Change
1,362.54
▼
−0.16%
Regular session
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 6 '26
JAGX
Jaguar Health, Inc.
vs
LLY
ELI Lilly & Co
0.39
▼
−3.29%
Price
1,362.54
▼
−0.16%
$140,268
Mkt cap
$1.2T
Q2 FY26
$1M
Revenue
$24.4B
Q3 FY26
FY25
$12M
Revenue
$65.2B
FY25
Change
Change
JAGX
0.39
▼
−3.29%
vs
LLY
1,362.54
▼
−0.16%
Regular session
Nov 6 '26